MYO
Myomo, Inc.$1.16+0.07 (+5.96%)Prev Close$1.09·MCap$32.0M·P/E—·Vol795.0K·Yield—
▲
Buys (12M)
9
$363.5K
▼
Sells (12M)
2
$109.9K
◆
Net Activity
Net Buyer
$253.6K
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Myomo, Inc. (MYO) has been dominated by buying, with 9 insider purchases totaling $363.5K and 2 insider sales totaling $109.9K. The most recent insider transaction was by KIRK THOMAS F (director), who purchased $24.8K worth of shares on Jun 1, 2026. Myomo, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $32.0M.
MYO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | KIRK THOMAS F | director | Buy | 25,000 | $0.99 | $24.8K | 653,863 |
| May 28, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 32,000 | $1.01 | $32.2K | 120,154 |
| May 18, 2026 | KIRK THOMAS F | director | Buy | 75,006 | $0.91 | $68.2K | 628,863 |
| May 15, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| Mar 16, 2026 | KIRK THOMAS F | director | Buy | 72,000 | $0.71 | $51.1K | 553,857 |
| Mar 12, 2026 | Getz Heather C | director | Buy | 70,000 | $0.73 | $51.0K | 111,754+168% |
| Nov 24, 2025 | KIRK THOMAS F | Buy | 7,437 | $0.72 | $5.4K | 481,857 | |
| Nov 21, 2025 | Crowley Thomas Aloysius Jr. | Buy | 4,385 | $0.74 | $3.2K | 75,748 | |
| Aug 26, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.15 | $57.5K | 474,420 | |
| Aug 19, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.10 | $55.0K | 424,420 | |
| Aug 18, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 50,000 | $0.95 | $47.3K | 1,259,013 |
| May 15, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 30,000 | $3.22 | $96.6K | 1,051,671 |
| May 15, 2025 | KIRK THOMAS F | Buy | 38,767 | $3.25 | $126.0K | 344,700 | |
| May 14, 2025 | KIRK THOMAS F | Buy | 50,000 | $3.35 | $167.5K | 305,933 | |
| Mar 14, 2025 | KIRK THOMAS F | Buy | 7,400 | $5.00 | $37.0K | 255,933 | |
| Mar 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247.6K | 140,572-25% |
| Mar 13, 2025 | Kovelman Harry | Chief Medical Officer | Sell | 30,000 | $5.50 | $165.0K | 97,973 |
| Sep 9, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 6,700 | $3.76 | $25.2K | 123,556 |
| Sep 5, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 2,029 | $4.01 | $8.1K | 130,395 |
| May 31, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 236,499+27% | |
| May 17, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 35,426 | $3.69 | $130.8K | 98,009-27% |
| Mar 18, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 186,499+37% | |
| Dec 14, 2023 | KIRK THOMAS F | Buy | 50,000 | $3.10 | $155.0K | 136,499+58% | |
| Sep 11, 2023 | Morris Milton Mayo | Buy | 15,000 | $1.06 | $15.9K | 77,933 | |
| Aug 31, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 48,400 | $0.74 | $36.0K | 878,245 |
| Aug 30, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 79,500 | $0.76 | $60.6K | 829,845 |
| Aug 30, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 41,666 | $0.60 | $25.0K | 352,193 |
| Aug 30, 2023 | Kovelman Harry | Chief Medical Officer | Buy | 8,333 | $0.60 | $5.0K | 149,556 |
| Jun 30, 2023 | Crowley Thomas Aloysius Jr. | Director | Sell | 12,901 | $2.09 | $27.0K | 9,401-58% |
| Jan 18, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 307,692 | $0.33 | $100.0K0.8% OS | 483,345+175% |
| Jan 18, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 76,923 | $0.33 | $25.0K | 163,527+89% |
| Jan 18, 2023 | Mitchell Micah | Chief Commerical Officer | Buy | 15,384 | $0.33 | $5.0K | 64,815+31% |
| Nov 22, 2022 | HENRY DAVID A | Chief Financial Officer | Buy | 9,000 | $0.55 | $5.0K | 86,604 |
| Aug 8, 2022 | Crowley Thomas Aloysius Jr. | Director | Sell | 7,141 | $1.71 | $12.2K | 12,901-36% |
| Mar 16, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.22 | $21.1K | 92,018 |
| Mar 11, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.63 | $23.1K | 87,018 |
| Nov 16, 2021 | GUDONIS PAUL R | Chief Executive Officer | Buy | 1,000 | $9.86 | $9.9K | 82,018 |
| Nov 16, 2021 | HENRY DAVID A | Chief Financial Officer | Buy | 1,000 | $8.86 | $8.9K | 35,618 |
MYO Insider Buying Activity
The following table shows recent insider purchases of Myomo, Inc. (MYO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | KIRK THOMAS F | director | Buy | 25,000 | $0.99 | $24.8K | 653,863 |
| May 18, 2026 | KIRK THOMAS F | director | Buy | 75,006 | $0.91 | $68.2K | 628,863 |
| Mar 16, 2026 | KIRK THOMAS F | director | Buy | 72,000 | $0.71 | $51.1K | 553,857 |
| Mar 12, 2026 | Getz Heather C | director | Buy | 70,000 | $0.73 | $51.0K | 111,754+168% |
| Nov 24, 2025 | KIRK THOMAS F | Buy | 7,437 | $0.72 | $5.4K | 481,857 | |
| Nov 21, 2025 | Crowley Thomas Aloysius Jr. | Buy | 4,385 | $0.74 | $3.2K | 75,748 | |
| Aug 26, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.15 | $57.5K | 474,420 | |
| Aug 19, 2025 | KIRK THOMAS F | Buy | 50,000 | $1.10 | $55.0K | 424,420 | |
| Aug 18, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 50,000 | $0.95 | $47.3K | 1,259,013 |
| May 15, 2025 | GUDONIS PAUL R | Chief Executive Officer | Buy | 30,000 | $3.22 | $96.6K | 1,051,671 |
| May 15, 2025 | KIRK THOMAS F | Buy | 38,767 | $3.25 | $126.0K | 344,700 | |
| May 14, 2025 | KIRK THOMAS F | Buy | 50,000 | $3.35 | $167.5K | 305,933 | |
| Mar 14, 2025 | KIRK THOMAS F | Buy | 7,400 | $5.00 | $37.0K | 255,933 | |
| May 31, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 236,499+27% | |
| Mar 18, 2024 | KIRK THOMAS F | Buy | 50,000 | $3.50 | $175.0K | 186,499+37% | |
| Dec 14, 2023 | KIRK THOMAS F | Buy | 50,000 | $3.10 | $155.0K | 136,499+58% | |
| Sep 11, 2023 | Morris Milton Mayo | Buy | 15,000 | $1.06 | $15.9K | 77,933 | |
| Aug 31, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 48,400 | $0.74 | $36.0K | 878,245 |
| Aug 30, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 79,500 | $0.76 | $60.6K | 829,845 |
| Aug 30, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 41,666 | $0.60 | $25.0K | 352,193 |
| Aug 30, 2023 | Kovelman Harry | Chief Medical Officer | Buy | 8,333 | $0.60 | $5.0K | 149,556 |
| Jan 18, 2023 | GUDONIS PAUL R | Chief Executive Officer | Buy | 307,692 | $0.33 | $100.0K0.8% OS | 483,345+175% |
| Jan 18, 2023 | HENRY DAVID A | Chief Financial Officer | Buy | 76,923 | $0.33 | $25.0K | 163,527+89% |
| Jan 18, 2023 | Mitchell Micah | Chief Commerical Officer | Buy | 15,384 | $0.33 | $5.0K | 64,815+31% |
| Nov 22, 2022 | HENRY DAVID A | Chief Financial Officer | Buy | 9,000 | $0.55 | $5.0K | 86,604 |
| Mar 16, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.22 | $21.1K | 92,018 |
| Mar 11, 2022 | GUDONIS PAUL R | Chief Executive Officer | Buy | 5,000 | $4.63 | $23.1K | 87,018 |
| Nov 16, 2021 | GUDONIS PAUL R | Chief Executive Officer | Buy | 1,000 | $9.86 | $9.9K | 82,018 |
| Nov 16, 2021 | HENRY DAVID A | Chief Financial Officer | Buy | 1,000 | $8.86 | $8.9K | 35,618 |
MYO Insider Selling Activity
The following table shows recent insider sales of Myomo, Inc. (MYO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | Kovelman Harry | officer: Chief Medical Officer | Sell | 32,000 | $1.01 | $32.2K | 120,154 |
| May 15, 2026 | Mitchell Micah | officer: Chief Commercial Officer | Sell | 90,231 | $0.86 | $77.7K | 109,478-45% |
| Mar 14, 2025 | Mitchell Micah | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247.6K | 140,572-25% |
| Mar 13, 2025 | Kovelman Harry | Chief Medical Officer | Sell | 30,000 | $5.50 | $165.0K | 97,973 |
| Sep 9, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 6,700 | $3.76 | $25.2K | 123,556 |
| Sep 5, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 2,029 | $4.01 | $8.1K | 130,395 |
| May 17, 2024 | Kovelman Harry | Chief Medical Officer | Sell | 35,426 | $3.69 | $130.8K | 98,009-27% |
| Jun 30, 2023 | Crowley Thomas Aloysius Jr. | Director | Sell | 12,901 | $2.09 | $27.0K | 9,401-58% |
| Aug 8, 2022 | Crowley Thomas Aloysius Jr. | Director | Sell | 7,141 | $1.71 | $12.2K | 12,901-36% |
MYO Insiders
Similar Stocks to MYO
ISRG
Intuitive Surgical, Inc.
$416.06-1.98%
$150.39B
SYK
Stryker Corporation
$302.94-0.69%
$116.96B
BSX
Boston Scientific Corporation
$47.98-0.58%
$71.81B
EW
Edwards Lifesciences Corporation
$88.75+2.66%
$49.79B
DXCM
DexCom, Inc.
$76.13+3.27%
$28.45B
RMD
ResMed Inc.
$188.49-0.92%
$27.64B
ZBH
Zimmer Biomet Holdings, Inc.
$83.39+1.35%
$15.93B
PEN
Penumbra, Inc.
$319.02+0.23%
$12.52B